NIBRT and San Jacinto College's biotech center in Houston train students for in-demand biomanufacturing and cell and gene therapy careers.

During our conversation, Seyf discussed his company’s involvement in the Australian ecosystem and how Australia is expanding ...

Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...

The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...

From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...

Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...

Eli Lilly and Company announced a $3 billion expansion to its injectable product manufacturing site. The facility produces glucagon-like peptide-1 (GLP-1) drug products, which are used to treat ...

Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its capabilities in antibody discovery and management. According to the company, its ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large molecule formats.